A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma-Reference-Cited by-同舟云学术

A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma

Published:2007-01 Issue:2 Volume:48 Page:374-380
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Lim Soon-Thye,Fayad L.,Tulpule A.,Modiano M.,Cabanillas F.,Laffranchi B.,Allievi C.,Bernareggi A.,Levine Alexandra M.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190601060496

Reference29 articles.

1. Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

2. Autologous Transplantation for Diffuse Aggressive Non-Hodgkin’s Lymphoma in Patients Never Achieving Remission: A Report from the Autologous Blood and Marrow Transplant Registry

3. Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma

4. Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma

5. LONG-TERM FOLLOW-UP OF PLATINUM-BASED LYMPHOMA SALVAGE REGIMENS

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Opinion on Pixantrone in the Treatment of Non-Hodgkin B-Cell Lymphoma;Therapeutics and Clinical Risk Management;2021-03

2. Pixantrone beyond monotherapy: a review;Annals of Hematology;2019-07-17

3. The rationale for combination therapy in patients with aggressive B-cell non-Hodgkin lymphoma: ten questions;Future Oncology;2019-01

4. In vitro demonstration of synergism with pixantrone combined with targeted agents in lymphomas;British Journal of Haematology;2018-12-19

5. An evaluation of pixantrone for the treatment of non-Hodgkin’s lymphoma;Expert Opinion on Pharmacotherapy;2018-10